PRA Health Sciences, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016
Net income
Cash flows from operating activities:
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense
Amortization of debt issuance costs and discount
Amortization of terminated interest rate swaps
Stock-based compensation expense
Non-cash transaction related stock-based compensation expense
Unrealized foreign currency losses (gains)
Loss on modification or extinguishment of debt
Loss on disposal of fixed assets
Change in fair value of acquisition-related contingent consideration
Equity in income of unconsolidated joint ventures
Unrealized loss on derivatives
Excess tax benefit from stock-based compensation
Deferred income taxes
Other reconciling items
Changes in operating assets and liabilities, net of acquired assets and assumed liabilities:
Accounts receivable and unbilled services
Prepaid expenses and other assets
Accounts payable and other liabilities
Income taxes
Net cash provided by operating activities
Advanced billings
Payment of acquisition-related contingent consideration

Net cash provided by operating activities

Cash flows from investing activities:
Purchase of fixed assets
Proceeds from the sale of fixed assets
Cash paid to terminate interest rate swaps
Cash (paid) received for interest on interest rate swap
Return of joint venture capital contribution
Contributions to unconsolidated joint ventures
Cash received from the sale of marketable securities
Acquisition of Symphony Health Solutions Corporation, net of cash acquired
Payment of Symphony Health Solutions Corporation contingent consideration
Acquisition of Parallel 6, Inc., net of cash acquired
Acquisition of Takeda PRA Development Center KK, net of cash acquired
Acquisition of Takeda Pharmaceutical Data Services, Ltd., net of cash acquired
Acquisition of Nextrials, Inc., net of cash acquired
Acquisition of Care Innovations, Inc., net of cash acquired
Payment of ClinStar, LLC working capital settlement
Net cash used in investing activities

Cash flows from financing activities:
Proceeds from issuance of long-term debt
Repayment of long-term debt
Proceeds from accounts receivable financing agreement
Repayment on accounts receivable financing agreement
Borrowings on line of credit
Repayments of line of credit
Payment of debt prepayment and debt extinguishment costs
Payment for debt issuance costs
Payment of common stock issuance costs
Excess tax benefit from stock-based compensation
Acquisition of noncontrolling interest
Proceeds from stock issued under employee stock purchase plan and stock option exercises
Cash, cash equivalents, and restricted cash, end of period
Taxes paid related to net shares settlement of equity awards
Payment of acquisition-related contingent consideration
Net cash provided by (used in) financing activities
Effects of foreign exchange changes on cash, cash equivalents, and restricted cash
Change in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash, beginning of year
Cash, cash equivalents, and restricted cash, end of year

Comments